C. Ziske

发表

p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells.

C. Bartz, C. Ziske, B. Wiedenmann, 1996, Gut.

A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients

T. Sauerbruch, A. Glasmacher, C. Ziske, 2003, Supportive Care in Cancer.

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

Y. Ko, P. Wernet, R. Souchon, 2005, The Lancet.

Neutropenic enterocolitis in adults: systematic analysis of evidence quality

T. Sauerbruch, A. Glasmacher, C. Ziske, 2005, European journal of haematology.

Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer.

C. Ziske, M. Gorschlueter, I. Schmidt-Wolf, 2008, In vivo.

What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study.

J. Vansteenkiste, C. Ziske, J. Lester, 2013, Lung cancer.

High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.

C. Mayr, B. Djulbegovic, A. Glasmacher, 2003, Haematologica.

Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice.

T. Sauerbruch, J. Prieto, C. Qian, 2004, Journal of hepatology.

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

T. Sauerbruch, A. Glasmacher, C. Ziske, 2003, British Journal of Cancer.

Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells

C. Ziske, K. Brand, I. Schmidt-Wolf, 2001, Cancer Gene Therapy.

Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2003, Gut.

Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology

T. Sauerbruch, A. Glasmacher, C. Ziske, 2002, British journal of haematology.

Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.

T. Sauerbruch, V. Schmitz, C. Ziske, 2003, Cancer research.

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2002, Cancer Immunology, Immunotherapy.

Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial

A. Glasmacher, C. Ziske, I. Schmidt-Wolf, 2003, Anti-cancer drugs.

Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2000, International Journal of Colorectal Disease.

Increase of the Immunostimulatory Effect of Dendritic Cells by Pulsing With CA 19-9 Protein

D. Huhn, T. Sauerbruch, C. Ziske, 2000, Journal of immunotherapy.

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

P. Albers, T. Sauerbruch, C. Ziske, 2002, Cancer Immunology, Immunotherapy.

Increase of In Vivo Antitumoral Activity by CD40L (CD154) Gene Transfer Into Pancreatic Tumor Cell-Dendritic Cell Hybrids

T. Sauerbruch, V. Schmitz, C. Ziske, 2009, Pancreas.

Infection with unexpected micro-organisms in splenectomised patients

C. Ziske, 2002, The Lancet.

Pharmacokinetics and efficacy of pegfilgrastim as hematopoietic support for dose-dense every-2-week chemo-immunotherapy with R-CHOP as first-line therapy in elderly patients with diffuse large B cell lymphoma.

A. Glasmacher, C. Ziske, I. Schmidt-Wolf, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.

A. Glasmacher, C. Ziske, M. Gorschlueter, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Acute transient encephalopathy after paclitaxel infusion: report of three cases.

T. Sauerbruch, U. Schlegel, C. Ziske, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.

T. Sauerbruch, V. Schmitz, C. Ziske, 2009, Pancreas.

Low Frequency of Enteric Infections by Salmonella, Shigella, Yersinia and Campylobacter in Patients with Acute Leukemia

T. Sauerbruch, A. Glasmacher, C. Ziske, 2002, Infection.

Clostridium difficile infection in patients with neutropenia.

T. Sauerbruch, A. Glasmacher, C. Ziske, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC

C. Ziske, I. Schmidt-Wolf, P. Buttgereit, 2004 .

Genetic Vaccines and Therapy

C. Ziske, I. Schmidt-Wolf, P. Buttgereit, 2004 .

Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature

C. Ziske, I. Schmidt-Wolf, Saineb Al Mansoor, 2013, German medical science : GMS e-journal.

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

P. Neuhaus, C. Ziske, B. Wiedenmann, 1996, Gut.

T guided pancreatic carcinoma mouse model activating lipopeptide MALP-2 in an ultrasound Tumour suppression induced by the macrophage

Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2003 .

Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2006, International immunology.

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

C. Ziske, I. Schmidt-Wolf, S. Nagaraj, 2004, Genetic vaccines and therapy.

Interactions Between Dendritic Cells and Cytokine-Induced Killer Cells Lead to an Activation of Both Populations

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2001, Journal of immunotherapy.

Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9.

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2001, Cancer Gene Therapy.

Invasive fungal infections in neutropenic enterocolitis: A systematic analysis of pathogens, incidence, treatment and mortality in adult patients

A. Glasmacher, V. Schmitz, C. Rabe, 2006, BMC infectious diseases.

Partial splenectomy

C. Ziske, Thomas Müller, 2002, The Lancet.

Littoral cell angioma as a rare cause of splenomegaly

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2001, Annals of Hematology.

Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice.

T. Sauerbruch, C. Ziske, N. Abraham, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Advances in the treatment of hairy-cell leukaemia.

A. Glasmacher, C. Ziske, I. Schmidt-Wolf, 2003, The Lancet. Oncology.

Dendritic cell, the immunotherapeutic cell for cancer.

C. Ziske, I. Schmidt-Wolf, S. Nagaraj, 2004, The Indian journal of medical research.

Transfection of human monocyte‐derived dendritic cells with CpG oligonucleotides

C. Ziske, I. Schmidt-Wolf, M. Gorschlueter, 2005, Immunology and cell biology.

Pancreas Carcinoma Antigen Fused to Invariant Chain Elicits T-Cell Response and Tumor Growth Inhibition

S. Frank, C. Ziske, I. Schmidt-Wolf, 2008, Pancreas.

Genetic Vaccines and Therapy

C. Ziske, I. Schmidt-Wolf, S. Nagaraj, 2004 .

Minimal size MIDGE vectors improve transgene expression in vivo.

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2007, In vivo.

Single versus tandem high dose chemotherapy (HDC) with hematopoietic stem cell support in patients with chemosensitive metastatic breast cancer (BC) -results from a multicenter phase III trial.

Y. Ko, A. Zander, C. Ziske, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma

Michael Reber, C. Ziske, I. Schmidt-Wolf, 2007, Supportive Care in Cancer.

Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison

T. Sauerbruch, A. Glasmacher, C. Ziske, 2003, Supportive Care in Cancer.

Real-Time High-Resolution Compound Imaging Allows Percutaneous Initiation and Surveillance in an Orthotopic Murine Pancreatic Cancer Model

T. Sauerbruch, V. Schmitz, C. Ziske, 2008, Pancreas.

Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites

T. Sauerbruch, C. Ziske, I. Schmidt-Wolf, 2006, European journal of gastroenterology & hepatology.

A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer.

H. Kölbl, V. Heinemann, C. Ziske, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial

W. Brugger, C. Ziske, R. Sauter, 2017, British journal of haematology.